Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers for novel combinatorial treatment strategies. (October 2020) - Lucas, L.; Cullum, R.; Dwivedi, V.; Waits, D.; Ghosh, T.; Kaufmann, D.; Knerr, E.; Markham, J.; Williams, E.; Woods, J.; Halanych, K.; David, A.; et al.